Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what recent assessment he has made of the likelihood that the COVAX facility will meet its objectives.

The Prime Minister has been clear in his commitment to equitable access to COVID-19 vaccines, that is why the UK has played a leading role in shaping the COVAX Facility. We are proud to be its largest bilateral donor, committing up to £548 million to the COVAX Advance Market Commitment (AMC) - the international initiative to support global equitable access to vaccines. Our commitment to the COVAX AMC will support access to COVID-19 vaccines for up to 92 developing countries by contributing to the supply of 1 billion doses by the end of 2021, and vaccinations for up to 500 million people (subject to vaccines successfully securing stringent regulatory approvals).

COVAX is on track to deliver its targets and is making good progress in negotiating deals with manufacturers.